Tremblant Capital Group
Tremblant Capital | Hedge Fund Tracker NotesThe following piece on Tremblant Capital Group is being published as part of our daily effort to track hedge fund events in the industry. To review other hedge fund research please see our Hedge Fund Tracker Tool.
Resource #1: Please see this link to review a recent 13F Holdings Analysis on Tremblant Capital: Tremblant Capital - 13F Hedge Fund Holdings.
Resource #2: In a 13G filing with the SEC, Tremblant Capital Group on Tuesday disclosed they own 1,758,311 shares of PDGI - PharmaNet Development Group, (formerly SFBC International). This represents a 9.0% ownership stake in the company. A 13G filing indicates passive ownership. This is a brand new position, as it was nowhere to be found in their most recent 13F filing where they disclosed their complete equity portfolio holdings as of June 30th, 2008.
Taken from Google Finance, PharmaNet Development Group Inc. (PDGI), formerly SFBC International, Inc., "is a global drug development services company providing clinical development services, including consulting, Phase I and bioequivalency clinical studies, and Phase II, III and IV clinical development programs to pharmaceutical, biotechnology, generic drug and medical device companies around the world. The Company conducts its operations in two segments: early stage and late stage clinical development."
You can view the 13G filing at the SEC.
Free Daily Hedge Fund Newsletter
Related to Tremblant Capital Hedge Fund Notes:
- Top 52 Most Popular Articles
- Hedge Fund Tracker Tool
- Financial Certification
- Hedge Fund Forum
- Hedge Fund Accountants
- Investment Consultants
- Investment Book
- Hedge Fund Terms and Definitions
- Geographical Hedge Fund Guides
- Hedge Fund Database
Tags: Bret Barakett, Tremblant Capital, Tremblant Capital Group, Tremblant Capital Management, Tremblant Capital Hedge Fund, Hedge Fund Manager Bret Barakett